Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Vilin Bio Med Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Vilin Bio Med Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Vilin Bio Med has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025

    21 Jan 2026, 10:20AM As of December 2025, 63.65% is owned by Indian Promoters and 36.35% by Public. <p align=justify> Top five Promoters holding highest number of shares o
  • Vilin Bio Med - Structural Digital Database

    19 Jan 2026, 6:16PM VILINBIO: Vilin Bio Med Limited has provided the Compliance Certificate for Structured Digital Database for the Quarter ended December 31, 2025
  • Vilin Bio Med - Copy of Newspaper Publication

    19 Jan 2026, 2:53PM Vilin Bio Med Limited has informed the Exchange about Copy of Newspaper Publication
  • Vilin Bio Med - Shareholders meeting

    17 Jan 2026, 5:23PM Vilin Bio Med Limited has informed the Exchange regarding Notice of undefined to be held on February 09, 2026
  • Vilin Bio Med - General Updates

    14 Jan 2026, 5:55PM Vilin Bio Med Limited has informed the Exchange about Revised Outcome of Board Meeting
  • Vilin Bio Med - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    13 Jan 2026, 2:14PM Vilin Bio Med Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Vilin Bio Med - Updates

    13 Jan 2026, 2:08PM Vilin Bio Med Limited has informed the Exchange regarding non-applicability of Corporate Governance Report for the Quarter ended December 31, 2025.
  • Vilin Bio Med - Resignation of Independent director

    10 Jan 2026, 8:54PM VILIN BIO MED LIMITED has informed the Exchange about Resignation of Independent director.
  • Vilin Bio Med - Outcome of Board Meeting

    10 Jan 2026, 8:49PM Vilin Bio Med Limited has informed the Exchange regarding the Board Meeting held on January 10, 2026.
  • Vilin Bio Med - General Updates

    10 Jan 2026, 2:14PM Vilin Bio Med Limited has informed the Exchange about clarification sought for Price Movement in Shares of the Company
  • Vilin Bio Med - Price movement

    9 Jan 2026, 8:55PM Significant movement in price has been observed in Vilin Bio Med Limited. The Exchange, in order to ensure that investors have latest relevant informa
  • Vilin Bio Med - Reply to Clarification- Financial results

    22 Dec 2025, 5:01PM The Exchange had sought clarification from Vilin Bio Med Limited for the quarter ended 30-Sep-2024 with respect to Regulation 33 of the SEBI (Listing
  • Vilin Bio Med - Outcome of Board Meeting

    12 Nov 2025, 4:56PM Vilin Bio Med Limited has submitted to the Exchange, the Unaudited Financial Results for the period ended September 30, 2025.

Key fundamentals

Evaluate the intrinsic value of Vilin Bio Med Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 25.6368 29.6699 15.6088 12.6957 12.8784
Liabilities 25.6368 29.6699 15.6088 12.6957 12.8784
Equity 13.95 13.95 9.95 3.3 3.3
Gross Profit 0.7868 0.8167 2.5733 0.7659 0.8566
Net Profit 0.2235 0.1624 1.245 0.0335 0.1213
Cash From Operating Activities 0.2175 -5.2998 -1.6584 0.2086 -1.0018
NPM(%) 1.5 1.02 10.11 0.29 1.03
Revenue 14.8099 15.8049 12.313 11.2149 11.7152
Expenses 14.0231 14.9882 9.7397 10.449 10.8586
ROE(%) 0.96 0.69 5.36 0.14 0.52

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Vilin Bio Med Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 686.40 0.02 0.00 0.00 301.39 0.73
Lotus Eye Hospital and Institute Ltd 116.37 4.99 363.66 0.00 3.55 0.00
Vaishali Pharma Ltd 8.58 -2.94 0.00 0.00 3.13 0.00
Astec Lifesciences Ltd 593.80 1.01 0.00 0.00 -604.77 0.00

Company Info

The Company was originally incorporated as a public limited company under the Companies Act, 1956 pursuant to a certificate of incorporation issued by the Registrar of Companies, Andhra Pradesh, Hyderabad dated June 29, 2005 with the name `Vilin Bio Med Limited'. We received a certificate of commencement of business on July 11, 2005 issued by Registrar of Companies, Andhra Pradesh, Hyderabad. The corporate identification number is U24230TG2005PLC046689. The Promoters of the Company are Viswa Prasad Sadhanala, Sadhanala Venkata Rao, D. Srinivasa Reddy And Ramesh Reddy Sama.Major Events and Milestones :2005- Company Incorporation2006- First Commercial production2007- Expansion of Phase2 for Beta Lactum facility with 16000 sft for Tablet, Capsule and Dry Syrup sections2010- We have received more than 1000 molecules Drug Approvals with different strengths in therapeutics of Diabetic, Neuro and Cardio.2012- 120 different styles of Packings including physician sample packs to meet all types packing requirements in the market2014- Added the Sachet section in Non-Beta Lactum facility2015- More than 20 different Punches in different dimensions of the tablet including size and volume to meet all the customer requirements2021- New Promoters are inducted to strengthen the Management of the Company2022- Company appointed Professionals on the Board to strengthen the Board and Corporate Governance.

The Company was originally incorporated as a public limited company under the Companies Act, 1956 pursuant to a certificate of incorporation issued by the Registrar of Companies, Andhra Pradesh, Hyderabad dated June 29, 2005 with the name `Vilin Bio Med Limited'. We received a certificate of commencement of business on July 11, 2005 issued by Registrar of Companies, Andhra Pradesh, Hyderabad. The corporate identification number is U24230TG2005PLC046689. The Promoters of the Company are Viswa Prasad Sadhanala, Sadhanala Venkata Rao, D. Srinivasa Reddy And Ramesh Reddy Sama.Major Events and Milestones :2005- Company Incorporation2006- First Commercial production2007- Expansion of Phase2 for Beta Lactum facility with 16000 sft for Tablet, Capsule and Dry Syrup sections2010- We have received more than 1000 molecules Drug Approvals with different strengths in therapeutics of Diabetic, Neuro and Cardio.2012- 120 different styles of Packings including physician sample packs to meet all types packing requirements in the market2014- Added the Sachet section in Non-Beta Lactum facility2015- More than 20 different Punches in different dimensions of the tablet including size and volume to meet all the customer requirements2021- New Promoters are inducted to strengthen the Management of the Company2022- Company appointed Professionals on the Board to strengthen the Board and Corporate Governance.

Read More

Parent Organisation

Vilin Bio Med Ltd.

Founded

29/06/2005

Managing Director

Mr.Madhusudhan Yadamakanti Reddy

NSE Symbol

VILINBIOSM

FAQ

The current price of Vilin Bio Med Ltd is

The 52-week high for Vilin Bio Med Ltd is

The market capitalization of Vilin Bio Med Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Vilin Bio Med Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Vilin Bio Med Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Vilin Bio Med Ltd shares.

The CEO of Vilin Bio Med Ltd is Mr.Madhusudhan Yadamakanti Reddy, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT